Prevalence of combined and noncombined dyslipidemia in an Iranian population

S Darroudi, M Saberi‐Karimian, M Tayefi… - Journal of clinical …, 2018 - Wiley Online Library
Background Combination of dyslipidemic phenotypes, including elevated plasma levels of
low‐density lipoprotein cholesterol (LDL‐C), elevated plasma triglycerides (TG), and …

Prevalence of combined and noncombined dyslipidemia in an Iranian population

S Darroudi, M Saberi-Karimian… - Journal of clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Combination of dyslipidemic phenotypes, including elevated plasma levels of
low-density lipoprotein cholesterol (LDL-C), elevated plasma triglycerides (TG), and …

Prevalence of combined and noncombined dyslipidemia in an Iranian population.

S Darroudi, M Saberi-Karimian, M Tayefi, S Arekhi… - 2018 - cabidigitallibrary.org
Background: Combination of dyslipidemic phenotypes, including elevated plasma levels of
low-density lipoprotein cholesterol (LDL-C), elevated plasma triglycerides (TG), and …

Prevalence of combined and noncombined dyslipidemia in an Iranian population.

S Darroudi, M Saberi-Karimian, M Tayefi… - Journal of Clinical …, 2018 - europepmc.org
Background Combination of dyslipidemic phenotypes, including elevated plasma levels of
low-density lipoprotein cholesterol (LDL-C), elevated plasma triglycerides (TG), and …

[PDF][PDF] Prevalence of combined and noncombined dyslipidemia in an Iranian population

2018 - researchgate.net
Background: Combination of dyslipidemic phenotypes, including elevated plasma levels of
low-density lipoprotein cholesterol (LDL-C), elevated plasma triglycerides (TG), and …

[HTML][HTML] Prevalence of combined and noncombined dyslipidemia in an Iranian population

S Darroudi, M Saberi‐Karimian, M Tayefi… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Background Combination of dyslipidemic phenotypes, including elevated plasma levels of
low‐density lipoprotein cholesterol (LDL‐C), elevated plasma triglycerides (TG), and …